Effectivenes of hepatitis B vaccination in STIKes Jenderal Achmad Yani Cimahi students
Abstract
Hepatitis B is an inflammatory disease of the liver caused due to an infection from the hepatitis B virus (HBV). This inflammatory liver disease can become chronic, causing liver cirrhosis, and then become cancerous. Hepatitis B vaccination process by injection. Hepatitis B antibodies can appear in response to Hepatitis B vaccination. The purpose of this study as an effort to decide the effectiveness of Hepatitis B vaccination by seeing whether active immunity has formed against infections caused by the Hepatitis B virus to Stikes Student Jenderal Ahmad Yani Cimahi. The research method used in this research is descriptive. Samples used in the study were 30 people who met the inclusion criteria. From the results of studies using the immunochromatographic method, all positive samples were found with hepatitis B antibodies. Based on the research can be concluded that the vaccination conducted on Stikes Jenderal Achmad Yani Cimahi has given effective results and has a protective titer to prevent hepatitis B virus infection that will attack his body.
Downloads
References
Astuti HP, Kusumawati E. Kajian Efektifitas Pemberian Vaksinasi Hepatitis B Terhadap Pembentukan Antibodi Anti HBs. KesMaDaSka. 2014:29-34.
Trihono. Hasil Riset Kesehatan Dasar. Vol 7.; 2013. doi:10.1517/13543784.7.5.803
Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices. MMWR Recomm Reports. 2018;67(1):1-31. doi:10.15585/mmwr.rr6701a1
Gerlich WH. Medical Virology of Hepatitis B: How it began and where we are now. Virol J. 2013;10:1-25. doi:10.1186/1743-422X-10-239
Pracoyo NE, Wibowo N. Faktor-Faktor yang Berhubungan dengan Tingkat Kekebalan Hepatitis B (anti-HBs) pada Anak Umur 1-14 Tahun dari Data Hasil Riskesdas 2007. Media Penelit dan Pengemb Kesehat. 2016;26(1):59-64. doi:10.22435/mpk.v26i1.4905.59-64
Wang X, Chen Q, Li H, et al. Asymptomatic hepatitis B carriers who were vaccinated at birth. J Med Virol. 2019;91(8):1489-1498. doi:10.1002/jmv.25461
Yao J, Ren J, Shen L, et al. The effects of booster vaccination of hepatitis B vaccine on anti-HBs negative children 11-15 years after primary vaccination. Hum Vaccin. 2011;7(10). doi:10.4161/hv.7.10.15990
Kemenkes RI. InfoDATIN: Situasi Dan Analisis Hepatitis.; 2014. doi:24427659
Akibu M, Nurgi S, Tadese M, Tsega WDi. Attitude and Vaccination Status of Healthcare Workers against Hepatitis B Infection in a Teaching Hospital, Ethiopia. Scientifica (Cairo). 2018;2018. doi:10.1155/2018/6705305
Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev. 2006;28(1):112-125. doi:10.1093/epirev/mxj009
N. et al. D. WHO guidelines on drawing blood : best practices in phlebotomy. World Heal Organ. 2010:1-105.
Wondfo. A rapid, one step test for the qualitative detection of Antibody to Hepatitis B Surface Antigen (HBsAb or anti-HBs) in serum or plasma. 2019.
Restuti HSJHS. Manfaat Imunisasi Pada Orang Dewasa. 2016;(January 2016):1-6.
Murphy K. Janeway C Immunobiology. 8th ed. (lawrence eleanor, ed.). Garland Science; 2012.
Hechavarría, Rodney; López G. Kuby IMUNOLOGY. Vol 53.; 2013. doi:10.1017/CBO9781107415324.004
Hechavarría, Rodney; López G. Vaccines. Vol 53.; 2013. doi:10.1017/CBO9781107415324.004
HCVG15-CHD-158. Understanding How Vaccines Work. Centers Dis Control. 2018;(July):1-2. https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-understand-color-office.pdf.
Claire Anne S. Vaccines - CH 2 How Do Vaccines Mediate Protection? Vaccines. 2013:16-23. doi:10.1016/B978-1-4557-0090-5.00004-5
Abernathy E. How the Immune System Works. Vol 87.; 2016. doi:10.2307/3470435
Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. J Clin Transl Hepatol. 2019;7(X):1-7. doi:10.14218/jcth.2018.00037
Copyright (c) 2019 The Author
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
